Citations

Mayo Clinic

Showing 10 of 108523 citations.

Variability of inter‐observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced renal cell carcinoma ( RCC ): independent analysis from a phase
Devine, Catherine , Fellman, Bryan , Urbauer, Diana L. , Abel, E. Jason , Bex, Axel , Lane, Brian R. , Thompson, R. Houston, Wood, Christopher G. , Karam, Jose Antonio , Allaf, Mohamad E

BJU International | June 1, 2015 | Volume: 117 | Issue: 4 | Pages: 629-635

10.1111/bju.13188 | PMID 26033220 Get It

Objective To evaluate how many patients could have undergone partial nephrectomy ( PN ) rather than radical nephrectomy ( RN ) before and after neoadjuvant axitinib therapy, as assessed by five independent urological oncologists, and to study the variability of inter‐observer agreement. Patients and Methods Pre‐ and post‐systemic treatment computed tomography scans from 22 patients with clear cell renal cell carcinoma in a phase II neoadjuvant axitinib trial were reviewed by five independent urological oncologists. R.E.N.A.L. nephrometry score and κ statistics were calculated. Results The median R.E.N.A.L. nephrometry score changed from 11 before treatment to 10 after treatment ( P = 0.002). Five tumours with moderate complexity before axitinib treatment remained moderate complexity after treatment. Of 17 tumours with high complexity before axitinib treatment, three became moderate complexity after treatment. The overall κ statistic was 0.611. Moderate‐complexity κ was 0.611 vs a high‐complexity κ of 0.428. Before axitinib treatment the κ was 0.550 vs 0.609 after treatment. After treatment with axitinib, all five reviewers agreed that only five patients required RN (instead of eight before treatment) and that 10 patients could now undergo PN (instead of three before treatment). The odds of PN feasibility were 22.8‐times higher after treatment with axitinib. Conclusions There is considerable variability in inter‐observer agreement on the feasibility of PN in patients treated with neoadjuvant targeted therapy. Although more patients were candidates for PN after neoadjuvant axitinib therapy, it remains difficult to identify these patients a priori .
Trisacryl Gelatin Microembolism and Metastases in the Lung after Renal Artery Embolization and Nephrectomy for Renal Cell Carcinoma
Alvarez, Andres Borja, Leventhal, Jack P., Cortese, Cherise , McComb, Barbara L., Thiel, David D. , Khoór, András , Borja Alvarez, Andres

Case Reports in Urology | May 31, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-3

10.1155/2015/916268 | PMID 26114008 Get It

This is the first report, to our knowledge, of widespread, histologically confirmed trisacryl gelatin pulmonary microembolism after renal artery embolization (RAE). In addition, this is the first report of lung involvement by both metastatic renal cell carcinoma (RCC) and an embolic agent used for RAE. The patient was a 63-year-old woman who recently presented with both dyspnea on exertion and productive cough. Her past medical history included clear cell RCC, which was treated with preoperative trisacryl gelatin microsphere RAE and right nephrectomy 9 years earlier. Computed tomography of the chest showed multiple lung nodules, a mass-like density in the left lower lobe, and mediastinal and hilar lymphadenopathy. Wedge resections of the lung showed multiple foci of metastatic RCC and extensive involvement of the muscular pulmonary arteries by trisacryl gelatin microspheres.
Diagnostic Challenge in a Patient with Severe Anion Gap Metabolic Acidosis
Kalimullah, Ejaaz A., Sohail, M. Rizwan , Ramar, Kannan , Tan, Eugene M. , Tan, E M

Case Reports in Critical Care | May 31, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-3

10.1155/2015/272914 | PMID 26113997 Get It

The approach to the patient with acute renal failure and elevated anion and osmolal gap is difficult. Differential diagnoses include toxic alcohol ingestion, diabetic or starvation ketoacidosis, or 5-oxoproline acidosis. We present a 76-year-old female with type 2 diabetes mellitus, who was found at home in a confused state. Laboratory analysis revealed serum pH 6.84, bicarbonate 5.8 mmol/L, pCO2 29 mmHg, anion gap 22.2 mmol/L, osmolal gap 17.4 mOsm/kg, elevated beta-hydroxybutyrate (4.2 mmol/L), random blood sugar 213 mg/dL, creatinine 2.1 mg/dL, and potassium 7.5 mmol/L with no electrocardiogram (EKG) changes. Fomepizole and hemodialysis were initiated for presumed ethylene glycol or methanol ingestion. Drug screens returned negative for ethylene glycol, alcohols, and acetaminophen, but there were elevated urine levels of acetone (11 mg/dL). The acetaminophen level was negative, and 5-oxoproline was not analyzed. After 5 days in the intensive care unit (ICU), her mental status improved with supportive care. She was discharged to a nursing facility. Though a diagnosis was not established, our patient’s presentation was likely due to starvation ketosis combined with chronic acetaminophen ingestion. Acetone ingestion is less likely. Overall, our case illustrates the importance of systematically approaching an elevated osmolal and anion gap metabolic acidosis.
Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women
Collins, Laura C. , Gelber, Shari , Marotti, Jonathan D. , Ruddy, Kathryn J. , Brachtel, Elena F. , Schapira, Lidia , Come, Steven E. , Wensley, Taylor, White, Sarah, Borges, Virginia F. , Schedin, Pepper , Tamimi, Rulla M. , White, Sarah Ann , Warner, Ellen , Winer, Eric P. , Partridge, Ann H.

The Oncologist | May 30, 2015 | Volume: 20 | Issue: 7 | Pages: 713-718

10.1634/theoncologist.2014-0412 | PMID 26025931 Get It

Abstract Background. The increase in breast cancer risk during pregnancy and postpartum is well known; however, the molecular phenotype of breast cancers occurring shortly after pregnancy has not been well studied. Given this, we investigated whether nulliparity and the time interval since pregnancy among parous women affects the breast cancer phenotype in young women. Materials and Methods. We examined molecular phenotype in relation to time since pregnancy in a prospective cohort of 707 young women (aged ≤40 years) with breast cancer. Parity was ascertained from study questionnaires. Using tumor histologic grade on central review and biomarker expression, cancers were categorized as luminal A- or B-like, HER2 enriched, and triple negative. Results. Overall, 32% were luminal A-like, 41% were luminal B-like, 9% were HER2 enriched, and 18% were triple negative. Although, numerically, patients diagnosed >5 years after pregnancy had more luminal A-like subtypes than women with shorter intervals since pregnancy, there was no evidence of a relationship between these intervals and molecular subtypes once family history of breast cancer and age at diagnosis were considered. Conclusion. Distribution of breast cancer molecular phenotype did not differ significantly among young women by parity or time interval since parturition when important predictors of tumor phenotype such as age and family history were considered. Implications for Practice: Distribution of breast cancer molecular phenotype did not differ among parous young women by time interval since pregnancy. The implication of these findings for clinical practice suggests that pregnancy-associated breast cancers may be seen up to 5 years beyond parturition.
The Mayo Clinic Arizona Spasmodic Dysphonia Experience
Patel, Alpen B., Bansberg, Stephen F. , Crujido, Lisa R., Crujido, Lisa, Adler, Charles H. , Lott, David G.

Annals of Otology, Rhinology & Laryngology | May 29, 2015 | Volume: 124 | Issue: 11 | Pages: 859-863

10.1177/0003489415588557 | PMID 26024910 Get It

Objective: Analyze demographic data collected over a 25-year experience of 718 patients with spasmodic dysphonia (SD) who have been treated with botulinum toxin-A (BoNT-A) and compare our data with previously published studies. Methods: Seven hundred eighteen patients with SD were treated with 6621 BoNT-A injections at Mayo Clinic Arizona between 1989 and 2014. All patients were treated by the same physician team. Background demographic data for each patient were recorded. Results: Of 718 patients, 557 patients were female (77.6%). Six hundred sixty of 718 (91.8%) patients had adductor SD (AdSD), and 58 of 718 (8.1%) patients had abductor SD (AbSD). Average age of onset was 51 years. Of 718 patients, 378 (52.6%) had vocal tremor (VT); VT was present in 54.4% of AdSD patients and 32.1% of AbSD patients. Thirty-seven of 718 (5.2%) patients had other dystonias, including cervical dystonia (2.3%), blepharospasm (1.4%), limb dystonia (1.1%), and oromandibular dystonia (0.3%). A positive family history of SD was present in only 6 of 718 patients (0.8%) and of other dystonias in 11 of 718 patients (1.5%). Conclusions: Spasmodic dysphonia is a chronic and potentially disabling focal laryngeal dystonia. The Mayo Clinic Arizona SD experience compares to prior reports and reveals a female preponderance, onset in middle age, infrequent hereditary pattern, high co-occurrence of VT, and low co-occurrence of other dystonias.
Variability in utilization of drug eluting stents in United States: Insights from nationwide inpatient sample
Panaich, Sidakpal , Badheka, Apurva O., Arora, Shilpkumar , Patel, Nileshkumar , Thakkar, Badal, Patel, Nilay , Singh, Vikas , Chothani, Ankit , Deshmukh, Abhishek , Agnihotri, Kanishk, Jhamnani, Sunny , Lahewala, Sopan , Manvar, Sohilkumar, Panchal, Vinaykumar , Patel, Achint , Bhatt, Parth , Savani, Chirag, Savani, Ghanshyambhai T., Solanki, Shantanu , Patel, Samir , Kaki, Amir , Mohamad, Tamam , Elder, Mahir, Kondur, Ashok , Cleman, Michael , Forrest, John K. , Schreiber, Theodore , Patel, Neil S , Patel, Jay N. , Grines, Cindy L. , Panaich, Sidakpal S

Catheterization and Cardiovascular Interventions | May 29, 2015 | Volume: 87 | Issue: 1 | Pages: 23-33

10.1002/ccd.25977 | PMID 26032938 Get It

ObjectivesWe studied the trends and predictors of drug eluting stent (DES) utilization from 2006 to 2011 to further expound the inter‐hospital variability in their utilization.BackgroundWe queried the Healthcare Cost and Utilization Project's Nationwide Inpatient Sample (NIS) between 2006 and 2011 using ICD‐9‐CM procedure code, 36.06 (bare metal stent) or 36.07 (drug eluting stents) for Percutaneous Coronary Intervention (PCI). Annual hospital volume was calculated using unique identification numbers and divided into quartiles for analysis.Methods and ResultsWe built a hierarchical two level model adjusted for multiple confounding factors, with hospital ID incorporated as random effects in the model. About 665,804 procedures (weighted n = 3,277,884) were analyzed. Safety concerns arising in 2006 reduced utilization DES from 90% of all PCIs performed in 2006 to a nadir of 69% in 2008 followed by increase (76% of all stents in 2009) and plateau (75% in 2011). Significant between‐hospital variation was noted in DES utilization irrespective of patient or hospital characteristics. Independent patient level predictors of DES were (OR, 95% CI, P‐value) age (0.99, 0.98–0.99, <0.001), female(1.12, 1.09–1.15, <0.001), acute myocardial infarction(0.75, 0.71–0.79, <0.001), shock (0.53, 0.49–0.58, <0.001), Charlson Co‐morbidity index (0.81,0.77–0.86, <0.001), private insurance/HMO (1.27, 1.20–1.34, <0.001), and elective admission (1.16, 1.05–1.29, <0.001). Highest quartile hospital (1.64, 1.25–2.16, <0.001) volume was associated with higher DES placement.ConclusionThere is significant between‐hospital variation in DES utilization and a higher annual hospital volume is associated with higher utilization rate of DES. © 2015 Wiley Periodicals, Inc.
Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk
Harriott, Andrea M. , Rayaprolu, Sruti , Soto‐Ortolaza, Alexandra I., Diehl, Nancy N. , Kanekiyo, Takahisa , Bu, Guojun , Malik, Rayaz A. , Ross, Owen A. , Soto‐Beasley, Alexandra I. , Heckman, Michael G. , Liu, Chin‐Chi , Cole, John W. , Meschia, James F. , Ross, Owen A , Bu, Guojun , Beasley, Alexandra I

European Journal of Neurology | May 29, 2015 | Volume: 22 | Issue: 8 | Pages: 1235-1241

10.1111/ene.12735 | PMID 26031789 Get It

Background and purposeLow density lipoprotein receptor related proteins (LRPs) 1 and 6 have been implicated in cerebral ischaemia. In addition, genetic variation in LRP1 and LRP6 has been linked with various factors that are related to risk of ischaemic stroke. The aim of this study was to examine the association of LRP1 and LRP6 gene variants with risk of ischaemic stroke as part of the Ischemic Stroke Genetics Study (ISGS).MethodsA Caucasian series (434 stroke patients, 319 controls) and an African American series (161 stroke patients, 116 controls) were included. Fourteen LRP6 variants and three LRP1 variants were genotyped and assessed for association with ischaemic stroke.ResultsIn the Caucasian series, significant associations with ischaemic stroke were observed for LRP6 rs2075241 [odds ratio (OR) 0.42, P = 0.023], rs2302685 (OR 0.44, P = 0.049), rs7975614 (OR 0.07, P = 0.017), rs10492120 (OR 0.62, P = 0.036) and rs10743980 (OR 0.66, P = 0.037). Risk of ischaemic stroke was significantly lower for carriers of any of these five protective LRP6 variants (24.0% of subjects) compared to non‐carriers (OR 0.57, P = 0.003). The protective association for LRP6 rs2075241 was observed at a similar magnitude across ischaemic stroke subtypes, whilst the effects of rs23022685, rs10492120 and rs10743980 were most apparent for cardioembolic and large vessel stroke. In the African American series, LRP1 rs11172113 was associated with an increased risk of stroke (OR 1.89, P = 0.006).ConclusionsThe results of our preliminary study provide evidence that LRP6 and LRP1 variants may be associated with risk of ischaemic stroke. Validation in larger studies is warranted.
Commentary
Frazee, Erin N, Frazee, Erin N, Kashani, Kianoush

Clinical Chemistry | May 29, 2015 | Volume: 61 | Issue: 6 | Pages: 808-808

10.1373/clinchem.2014.231829 Get It

Transcatheter closure of postmyocardial infarction, iatrogenic, and postoperative ventricular septal defects: The Mayo Clinic experience
Egbe, Alexander C. , Poterucha, Joseph T., Rihal, Charanjit S. , Taggart, Nathaniel W. , Cetta, Frank , Pollak, Peter , Reeder, Guy S., Hagler, Donald J. , Cabalka, Allison K. , Pollak, Peter M, Rihal, Charanjit S. , Taggart, Nathaniel W

Catheterization and Cardiovascular Interventions | May 29, 2015 | Volume: 86 | Issue: 7 | Pages: 1264-1270

10.1002/ccd.25989 | PMID 26033272 Get It

Objectives To determine event‐free survival after transcatheter closure of ventricular septal defect (VSD), and to identify predictors of adverse events (AE) in post myocardial infarction VSD (post‐MI VSD) subgroup. Background There are limited data on mid‐term follow‐up after transcatheter VSD closure. Methods Retrospective review of 27 cases of transcatheter VSD closure (post‐MI = 18 and non‐ischemic = 9) performed from 1999 to 2013. We defined AE as death, device embolization, hemolysis requiring blood transfusion, heart block and reintervention. Results In the post‐MI VSD subgroup, mean age and follow‐up was 69 ± 11 and 7.3 ± 7 years, respectively. AE occurred in 8 (44%) patients (death‐3, device embolization‐1, hemolysis‐1, surgical VSD closure‐2, reintervention‐1). Event‐free survival was 56% at 1 month and 5 years, and all AE occurred in the periprocedural period. Cardiogenic shock (HR: 3.21, CI: 1.82–5.41, P = 0.002), and VSD closure in acute phase (HR: 2.14, CI: 1.12–4.31, P = 0.004) were independent predictors of AE. In the non‐ischemic VSD subgroup, mean age and follow‐up was 49 ± 15 and 8.7 ± 8 years, respectively. AE occurred in 3 (33%) patients (late death‐1, surgical VSD closure‐2). For the entire cohort, freedom from death was 89% and 85% at 1 month and 5 years, and event‐free survival was 70% and 61% at 1 month and 5 years. Conclusions Transcatheter closure of post‐MI VSD carries a moderate risk of periprocedural complications but low event rates afterwards. By comparison, device closure of non‐ischemic VSD has lower periprocedural morbidity but some patients continued to experience AE during follow‐up. © 2015 Wiley Periodicals, Inc.
Aqueous Humor Outflow: Dynamics and Disease
Chowdhury, Uttio Roy, Hann, Cheryl R., Fautsch, Michael P. , Roy Chowdhury, Uttio, Stamer, William Daniel

Investigative Opthalmology & Visual Science | May 29, 2015 | Volume: 56 | Issue: 5 | Pages: 2993

10.1167/iovs.15-16744 | PMID 26024085 Get It